SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $386,000 | -25.8% | 11,029 | -29.5% | 0.30% | -15.1% |
| Q4 2018 | $520,000 | -48.1% | 15,649 | -21.3% | 0.35% | -33.0% |
| Q3 2018 | $1,001,000 | -16.8% | 19,874 | -1.1% | 0.52% | -18.6% |
| Q2 2018 | $1,203,000 | +16.1% | 20,094 | -11.2% | 0.64% | +11.6% |
| Q1 2018 | $1,036,000 | +9.1% | 22,630 | -5.1% | 0.58% | +8.1% |
| Q4 2017 | $950,000 | -8.5% | 23,843 | -8.1% | 0.53% | -8.4% |
| Q3 2017 | $1,038,000 | -34.9% | 25,958 | -29.8% | 0.58% | -36.3% |
| Q2 2017 | $1,594,000 | -1.1% | 36,973 | -28.2% | 0.92% | -7.6% |
| Q1 2017 | $1,611,000 | +25.1% | 51,459 | +0.8% | 0.99% | +11.0% |
| Q4 2016 | $1,288,000 | -11.7% | 51,026 | -13.5% | 0.89% | -9.3% |
| Q3 2016 | $1,459,000 | +17.8% | 58,996 | -3.0% | 0.98% | +11.3% |
| Q2 2016 | $1,239,000 | +26.4% | 60,816 | -5.4% | 0.88% | +22.1% |
| Q1 2016 | $980,000 | +113.0% | 64,275 | +87.9% | 0.72% | +111.1% |
| Q4 2015 | $460,000 | – | 34,215 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |